Regeneron Pharmaceuticals Inc (REGN)
960.52
-4.66
(-0.48%)
USD |
NASDAQ |
Mar 18, 16:00
958.79
-1.73
(-0.18%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Assets (Quarterly): 33.08B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 33.08B |
September 30, 2023 | 32.16B |
June 30, 2023 | 30.66B |
March 31, 2023 | 30.06B |
December 31, 2022 | 29.21B |
September 30, 2022 | 27.68B |
June 30, 2022 | 27.21B |
March 31, 2022 | 26.35B |
December 31, 2021 | 25.43B |
September 30, 2021 | 23.67B |
June 30, 2021 | 21.49B |
March 31, 2021 | 17.77B |
December 31, 2020 | 17.16B |
September 30, 2020 | 16.08B |
June 30, 2020 | 14.43B |
March 31, 2020 | 15.76B |
December 31, 2019 | 14.81B |
September 30, 2019 | 13.94B |
June 30, 2019 | 13.17B |
March 31, 2019 | 12.85B |
December 31, 2018 | 11.73B |
September 30, 2018 | 10.81B |
June 30, 2018 | 9.952B |
March 31, 2018 | 9.373B |
December 31, 2017 | 8.764B |
Date | Value |
---|---|
September 30, 2017 | 8.701B |
June 30, 2017 | 8.106B |
March 31, 2017 | 7.817B |
December 31, 2016 | 6.973B |
September 30, 2016 | 6.828B |
June 30, 2016 | 6.205B |
March 31, 2016 | 5.904B |
December 31, 2015 | 5.609B |
September 30, 2015 | 5.183B |
June 30, 2015 | 4.527B |
March 31, 2015 | 4.199B |
December 31, 2014 | 3.838B |
September 30, 2014 | 3.739B |
June 30, 2014 | 3.456B |
March 31, 2014 | 3.260B |
December 31, 2013 | 2.951B |
September 30, 2013 | 2.640B |
June 30, 2013 | 2.378B |
March 31, 2013 | 2.276B |
December 31, 2012 | 2.080B |
September 30, 2012 | 1.661B |
June 30, 2012 | 1.458B |
March 31, 2012 | 1.350B |
December 31, 2011 | 1.324B |
September 30, 2011 | 983.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.85B
Minimum
Mar 2019
33.08B
Maximum
Dec 2023
22.15B
Average
22.58B
Median
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 64.01B |
Vertex Pharmaceuticals Inc | 22.73B |
Pfizer Inc | 226.50B |
AbbVie Inc | 134.71B |
Puma Biotechnology Inc | 230.53M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 7.107B |
Shareholders Equity (Quarterly) | 25.97B |
Debt to Equity Ratio | 0.0763 |
Current Ratio | 5.69 |
Net Debt Paydown Yield | -0.00% |